RFK Jr. has launched a comprehensive review of the abortion pill mifepristone, which is used in two-thirds of abortions, following requests for an investigation into its safety. This initiative coincides with federal agencies examining the safety protocols of the medication, raising concerns about potential limitations on access. The Trump administration is also involved, reviewing safety measures and considering new restrictions on the drug. Advocates and health officials maintain that mifepristone is safer than many commonly used medications, but the ongoing scrutiny leads to fears of a nationwide ban. Health and Human Services (HHS) and the FDA are undertaking studies in response to concerns raised by state attorneys general. As the landscape surrounding medication abortion evolves, the debate over the safety and accessibility of mifepristone intensifies.